brimonidine tartrate has been researched along with Corneal Neovascularization in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, Y; Kato, H; Kinoshita, S; Maruyama, Y; Mori, K; Sotozono, C; Ueno, M; Yokoi, N | 1 |
| Inoue, Y; Takai, Y; Tanito, M; Tsujinaka, A | 1 |
| Manabe, Y; Mochizuki, K; Sawada, A | 1 |
| Avni, I; Barak, A; Ben-Shoshan, J; George, J; Levkovitch-Verbin, H; Luboshits, G; Rosner, M; Schwartz, S; Ziv, H | 1 |
4 other study(ies) available for brimonidine tartrate and Corneal Neovascularization
| Article | Year |
|---|---|
Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis; Corneal Neovascularization; Female; Glaucoma; Humans; Ophthalmic Solutions | 2017 |
A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Corneal Neovascularization; Corneal Opacity; Corneal Stroma; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Male; Slit Lamp Microscopy; Time Factors; Visual Acuity | 2019 |
Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Blepharitis; Brimonidine Tartrate; Conjunctivitis; Corneal Neovascularization; Corneal Opacity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Tension Glaucoma; Male; Ophthalmic Solutions; Sulfonamides; Thiazines; Thiophenes | 2020 |
Drug modification of angiogenesis in a rat cornea model.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Corneal Neovascularization; Corneal Stroma; Disease Models, Animal; Drug Implants; Fibroblast Growth Factor 2; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Timolol | 2008 |